Human papillomavirus DNA in sera of cervical cancer patients as tumor marker
- 4 November 2003
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 202 (2) , 231-239
- https://doi.org/10.1016/j.canlet.2003.09.006
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Low Incidence of HPV DNA in Sera of Pretreatment Cervical Cancer PatientsGynecologic Oncology, 2001
- Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimensJournal of Virological Methods, 2000
- Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age-related patterns for high-risk and low-risk typesInternational Journal of Cancer, 2000
- The Origin and Mechanism of Circulating DNAAnnals of the New York Academy of Sciences, 2000
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolatesArchiv für die gesamte Virusforschung, 1998
- A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapingsJournal of Clinical Microbiology, 1997
- Detection and Typing of Multiple Genital Human Papillomaviruses by DNA Amplification with Consensus PrimersJapanese Journal of Cancer Research, 1991
- Amplification and typing of multiple cervical cancer‐associated human papillomavirus DNAS using a single pair of primersInternational Journal of Cancer, 1990
- Determination of circulating DNA levels in patients with benign or malignant gastrointestinal diseaseCancer, 1983